To Determine Bioequivalence Under Fasting Conditions Clinical Trial
Official title:
Randomized, 2-way Crossover, Comparative Bioequivalence Study of Par Pharmaceutical Inc. (USA) and Oclassen Pharmaceuticals Inc. (USA) (Monodox(R)) Doxycycline Monohydrate Equivalent to 100 mg Doxycycline Administered as a Single Dose of 100 mg In Healthy Adult Males Under Fasting Conditions
The purpose of this study is to compare the single-dose bioequivalence of Par and Oclassen doxycycline monohydrate, 100 mg.
To compare the single-dose bioequivalence of Par and Oclassen (Monodox(R)), 100 mg doxycycline under fasting conditions. ;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00653380 -
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653120 -
Bioavailability Study of Propranolol Under Fasting Conditions
|
Phase 2 | |
Completed |
NCT00653315 -
Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652912 -
Bioavailability Study of Clonazepam ODT Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653419 -
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652795 -
Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT01380457 -
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652639 -
Bioavailability Study of Clonazepam Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653055 -
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653549 -
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
|
Phase 1 |